Cannell Thomas R

EVP, COO, Pres Global Com Prod at Orexigen Therapeutics, Inc. · on record since Dec 2, 2016
Director at Eleven Biotherapeutics, Inc. · on record since Aug 9, 2018
President and CEO at Eleven Biotherapeutics, Inc. · on record since Aug 9, 2018

Insider trading activity of Cannell Thomas R

Transactions on record: 23; since Mar 31, 2015

Open-market buys: 0

Open-market sells: 3; $319.3K

Companies traded: 2; last filing Mar 6, 2023

Figures computed from official regulatory filings — methodology.

Companies where Cannell Thomas R has traded

Eleven Biotherapeutics, Inc.9 tx · $677.3K · Mar 6, 2023
Orexigen Therapeutics, Inc.14 tx · $17.4K · Oct 17, 2017

Track record of Cannell Thomas R

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Cannell Thomas R

Co-insiders of Cannell Thomas R

DIXON WENDY LEleven Biotherapeutics, Inc. +1
Forbes MonicaEleven Biotherapeutics, Inc. +1
Honig PeterEleven Biotherapeutics, Inc. +1
Keyes Jason AEleven Biotherapeutics, Inc. +1
ACE HEATHER SOrexigen Therapeutics, Inc.
AFEYAN NOUBAREleven Biotherapeutics, Inc.
Anderson KirstinEleven Biotherapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Eleven Biotherapeutics, Inc.	Mar 6, 2023	Sell	-208,923	0.59 USD	$123.3K	SEC
Eleven Biotherapeutics, Inc.	Mar 6, 2023	Sell	-278,564	0.59 USD	$164.4K	SEC
Eleven Biotherapeutics, Inc.	Mar 6, 2023	Exercise	606,800	0.59 USD	$358K	SEC
Eleven Biotherapeutics, Inc.	Feb 23, 2023	Sell	-53,727	0.59 USD	$31.7K	SEC
Eleven Biotherapeutics, Inc.	Feb 23, 2022	Award	606,800	0.00 USD	$0	SEC
Eleven Biotherapeutics, Inc.	Feb 23, 2021	AwardD	2,000,000	0.00 USD	$0	SEC
Eleven Biotherapeutics, Inc.	Feb 18, 2020	AwardD	1,450,000	0.00 USD	$0	SEC
Eleven Biotherapeutics, Inc.	Feb 25, 2019	AwardD	1,000,000	0.00 USD	$0	SEC
Eleven Biotherapeutics, Inc.	Aug 9, 2018	AwardD	1,350,000	0.00 USD	$0	SEC
Orexigen Therapeutics, Inc.	Oct 17, 2017	AwardD	91,200	0.00 USD	$0	SEC
Orexigen Therapeutics, Inc.	Jun 2, 2017	Award	2,119	1.55 USD	$3.3K	SEC
Orexigen Therapeutics, Inc.	Feb 7, 2017	AwardD	72,000	—	—	SEC
Orexigen Therapeutics, Inc.	Feb 7, 2017	AwardD	144,000	—	—	SEC
Orexigen Therapeutics, Inc.	Dec 2, 2016	Award	291	1.67 USD	$486	SEC
Orexigen Therapeutics, Inc.	Jul 14, 2016	AwardD	31,500	—	—	SEC
Orexigen Therapeutics, Inc.	Jul 14, 2016	AwardD	157,500	—	—	SEC
Orexigen Therapeutics, Inc.	Jul 14, 2016	AwardD	262,500	—	—	SEC
Orexigen Therapeutics, Inc.	Jul 14, 2016	AwardD	52,500	—	—	SEC
Orexigen Therapeutics, Inc.	Jun 2, 2016	Award	9,632	0.34 USD	$3.3K	SEC
Orexigen Therapeutics, Inc.	Feb 4, 2016	AwardD	390,000	—	—	SEC
Orexigen Therapeutics, Inc.	Feb 4, 2016	Award	5,091	2.03 USD	$10.3K	SEC
Orexigen Therapeutics, Inc.	Feb 4, 2016	AwardD	350,000	0.00 USD	$0	SEC
Orexigen Therapeutics, Inc.	Mar 31, 2015	AwardD	425,000	—	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Eleven Biotherapeutics, Inc.	Mar 6, 2023	Sell	-208,923	0.59 USD	$123.3K	SEC
Eleven Biotherapeutics, Inc.	Mar 6, 2023	Sell	-278,564	0.59 USD	$164.4K	SEC
Eleven Biotherapeutics, Inc.	Mar 6, 2023	Exercise	606,800	0.59 USD	$358K	SEC
Eleven Biotherapeutics, Inc.	Feb 23, 2023	Sell	-53,727	0.59 USD	$31.7K	SEC
Eleven Biotherapeutics, Inc.	Feb 23, 2022	Award	606,800	0.00 USD	$0	SEC
Eleven Biotherapeutics, Inc.	Feb 23, 2021	AwardD	2,000,000	0.00 USD	$0	SEC
Eleven Biotherapeutics, Inc.	Feb 18, 2020	AwardD	1,450,000	0.00 USD	$0	SEC
Eleven Biotherapeutics, Inc.	Feb 25, 2019	AwardD	1,000,000	0.00 USD	$0	SEC
Eleven Biotherapeutics, Inc.	Aug 9, 2018	AwardD	1,350,000	0.00 USD	$0	SEC
Orexigen Therapeutics, Inc.	Oct 17, 2017	AwardD	91,200	0.00 USD	$0	SEC
Orexigen Therapeutics, Inc.	Jun 2, 2017	Award	2,119	1.55 USD	$3.3K	SEC
Orexigen Therapeutics, Inc.	Feb 7, 2017	AwardD	72,000	—	—	SEC
Orexigen Therapeutics, Inc.	Feb 7, 2017	AwardD	144,000	—	—	SEC
Orexigen Therapeutics, Inc.	Dec 2, 2016	Award	291	1.67 USD	$486	SEC
Orexigen Therapeutics, Inc.	Jul 14, 2016	AwardD	31,500	—	—	SEC
Orexigen Therapeutics, Inc.	Jul 14, 2016	AwardD	157,500	—	—	SEC
Orexigen Therapeutics, Inc.	Jul 14, 2016	AwardD	262,500	—	—	SEC
Orexigen Therapeutics, Inc.	Jul 14, 2016	AwardD	52,500	—	—	SEC
Orexigen Therapeutics, Inc.	Jun 2, 2016	Award	9,632	0.34 USD	$3.3K	SEC
Orexigen Therapeutics, Inc.	Feb 4, 2016	AwardD	390,000	—	—	SEC
Orexigen Therapeutics, Inc.	Feb 4, 2016	Award	5,091	2.03 USD	$10.3K	SEC
Orexigen Therapeutics, Inc.	Feb 4, 2016	AwardD	350,000	0.00 USD	$0	SEC
Orexigen Therapeutics, Inc.	Mar 31, 2015	AwardD	425,000	—	—	SEC